Frank Neumann
Corporate Officer/Principal bij KITE PHARMA INC
Profiel
Frank Neumann is currently the Head-Clinical Development at Kite Pharma, Inc. He was previously the Vice President & Head-Oncology Clinical Research at bluebird bio, Inc. and the Chief Medical Officer at Verastem, Inc. He holds a doctorate degree from the University of Bonn and Heinrich-Heine-Universität Düsseldorf.
Actieve functies van Frank Neumann
| Bedrijven | Functie | Begin |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01-01-2021 |
Eerdere bekende functies van Frank Neumann
| Bedrijven | Functie | Einde |
|---|---|---|
| VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 20-01-2021 |
| BLUEBIRD BIO, INC. | Corporate Officer/Principal | - |
Opleiding van Frank Neumann
| University of Bonn | Doctorate Degree |
| Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
